Evidence map›Paper›PMID 29637171›Full record

ArticleBMJ paediatrics open2017

Probiotics, prematurity and neurodevelopment: follow-up of a randomised trial.

Susan E Jacobs, Leah Hickey, Susan Donath, Gillian F Opie, Peter J Anderson, Suzanne M Garland, Jeanie L Y Cheong, ProPremsStudy Groups

Registry-linked trialOpen access · diamondAbstract read
In one paragraph

Article in BMJ paediatrics open, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05945017 (Probiotics and the Neurodevelopment in the Premature Infant <32 Weeks Gestational Age and <1500g), which is not on this map. Cited by 36 papers, 10 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
36citing papers in PubMed, 10 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05945017 naactive not recruitingnot on this map

Probiotics and the Neurodevelopment in the Premature Infant <32 Weeks Gestational Age and <1500g

TypeinterventionalSponsorFundacion Clinic per a la Recerca BiomédicaRan2014 to 2027Enrolled233ConditionsInfant, Newborn, Diseases, Infant DevelopmentArmsInfloran® -Berne, Switzerland- (Bifidobacterium bifidum NCDO 2203 and Lactobacillus acidophilus NCDO 1748
3 · Its place in the literature

Who cites it

36 citing papers in PubMed, 10 syntheses or guidelines pooled it, 55 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Probiotics in infants for prevention of allergic disease.The Cochrane database of systematic reviews · 2025
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Pooled it
  9. Pooled it
  10. Pooled it
  11. Trial
  12. Trial
  13. Article
  14. Article
  15. Unplanned natural experiment: probiotics prevent necrotizing enterocolitis, a single center quality improvement report.Journal of perinatology : official journal of the California Perinatal Association · 2025
    Article
  16. Review
  17. Review
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Susan E JacobsNeonatal Services, The Royal Women's Hospital, Melbourne, Australia.
Leah HickeyDepartment of Neonatal Medicine, The Royal Children's Hospital, Melbourne, Australia.
Susan DonathClinical Epidemiology and Biostatistics Unit, Murdoch Childrens Research Institute, Melbourne, Australia.
Gillian F OpieDepartment of Obstetrics and Gynaecology, University of Melbourne, Melbourne, Australia.
Peter J AndersonClinical Sciences, Murdoch Childrens Research Institute, Melbourne, Australia.
Suzanne M GarlandWomen's Centre for Infectious Diseases and Department of Microbiology and Infectious Diseases, The Royal Women's Hospital, Melbourne, Australia.
Jeanie L Y CheongNeonatal Services, The Royal Women's Hospital, Melbourne, Australia.
ProPremsStudy Groups
Murdoch Children's Research Institute · AURoyal Children's Hospital · AUMercy Hospital for Women · AUUniversity of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo determine the impact of one probiotics combination on the neurodevelopment of very preterm children at 2-5 years corrected gestational age (CA).

designFollow-up study of survivors of a double-blinded, placebo-controlled, randomised trial of probiotic effects on late-onset sepsis in very preterm infants that found reduced necrotising enterocolitis.

setting10 tertiary perinatal centres in Australia and New Zealand. PATIENTS: 1099 very preterm infants born <32 weeks' gestation and weighing <1500 g.

interventionProbiotics (

main outcome measuresMajor neurodevelopmental impairment comprised any of moderate/severe cerebral palsy (Gross Motor Function Classification System score 2-5), motor impairment (Bayley-III Motor Composite Scale <

resultsOutcome data were available for 735 (67%) participants, with 71 deaths and 664/1028 survivors assessed at a mean age of 30 months. Survival free of major neurodevelopmental impairment was comparable between groups (probiotics 281 (75.3%) vs placebo 271 (74.9%); relative risk 1.01 (95% CI 0.93 to 1.09)). Rates of deafness were lower in probiotic-treated children (0.6% vs 3.4%).

conclusionAdministration of the probiotics combination TRIAL REGISTRATION NUMBER: Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN012607000144415.

Indexed as

Neurodevelopment

Identifiers

PMID29637171
PMCPMC5862156
OpenAlexW2770323313

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.